Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spontaneous Tumor Models.

Autor: Ciccolella M; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy., Andreone S; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy., Mancini J; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy., Sestili P; National Center for the Control and Evaluation of Medicines, 00161 Rome, Italy., Negri D; Department of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy., Pacca AM; Animal Research and Welfare Centre, Istituto Superiore di Sanità, 00161 Rome, Italy., D'Urso MT; Animal Research and Welfare Centre, Istituto Superiore di Sanità, 00161 Rome, Italy., Macchia D; Animal Research and Welfare Centre, Istituto Superiore di Sanità, 00161 Rome, Italy., Canese R; Core Facilities, Istituto Superiore di Sanità, 00161 Rome, Italy., Pang K; Biolingus AG, CH-6052 Hergiswil NW, Switzerland.; Murdoch Children's Research Institute, Parkville 3052, Australia.; The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia.; Department of Paediatrics, University of Melbourne, Parkville 3010, Australia., SaiYing Ko T; Biolingus AG, CH-6052 Hergiswil NW, Switzerland., Decadt Y; Biolingus AG, CH-6052 Hergiswil NW, Switzerland., Schiavoni G; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy., Mattei F; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy., Belardelli F; Institute of Translational Pharmacology, Consiglio Nazionale delle Ricerche, 00133 Rome, Italy., Aricò E; Core Facilities, Istituto Superiore di Sanità, 00161 Rome, Italy., Bracci L; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy.

Publikováno v: Cells [Cells] 2021 Apr 08; Vol. 10 (4). Date of Electronic Publication: 2021 Apr 08.